Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sports Nutrition Products Mark Start Of FDA’s Picamilon Enforcement

This article was originally published in The Tan Sheet

Executive Summary

Five warnings likely mark the start of a sweep to rid the US market of products containing the ingredient that the agency initially identified as violative in a recent declaration submitted for the Oregon attorney general’s complaint against GNC and that Senator McCaskill says FDA should prevent firms from using.

Advertisement

Related Content

ProSupps Expands Picamilon Recall To 18 More Products
Regulatory Problems Mount For Supplement Firm Following Recall
Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities
FTC Enforcement Hangs Over Memory Product Firm After Overlooking NAD Review
Kirkman Acquires Rose, IQ Recalls Picamilon Supplement: Health And Wellness Industry News Roundup
New York AG And FTC Target Prevagen Memory Claims
NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS108064

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel